Aroa Biosurgery Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 221

Employees

  • Stock Symbol
  • ARX

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.25
  • (As of Tuesday Closing)

Aroa Biosurgery General Information

Description

Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Contact Information

Website
www.aroa.com
Formerly Known As
Mesynthes
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 64 Richard Pearse Drive Mangere
  • Auckland, 2022
  • New Zealand
+64 09
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Stock Exchange
ASX
Vertical(s)
Digital Health, Life Sciences
Corporate Office
  • 64 Richard Pearse Drive Mangere
  • Auckland, 2022
  • New Zealand
+64 09

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aroa Biosurgery Stock Performance

As of 22-Apr-2025, Aroa Biosurgery’s stock price is $0.25. Its current market cap is $86.6M with 346M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.25 $0.26 $0.21 - $0.51 $86.6M 346M 380K -$0.01

Aroa Biosurgery Financials Summary

As of 30-Sep-2024, Aroa Biosurgery has a trailing 12-month revenue of $46.8M.

In Thousands,
USD 		TTM 30-Sep-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 125,287 107,540 217,593 163,121
Revenue 46,783 42,066 39,427 27,604
EBITDA (1,719) (3,700) 1,571 (3,047)
Net Income (4,629) (6,473) (246) (5,834)
Total Assets 67,068 66,234 73,045 78,503
Total Debt 4,368 4,434 4,455 4,095
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aroa Biosurgery Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aroa Biosurgery‘s full profile, request access.

Request a free trial

Aroa Biosurgery Patents

  • 71

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 47

    Pending

  • Expiring in next 12 mo

Aroa Biosurgery Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023900188-A0 Methods and agents for treating respiratory inflammation and associated diseases and conditions Inactive 27-Jan-2023
AU-2023900187-A0 Methods and agents for treating soft tissue inflammation and associated diseases and conditions Inactive 27-Jan-2023
AU-2023900186-A0 Methods and agents for treating tissue ischemia and associated diseases and conditions Inactive 27-Jan-2023
US-20240293264-A1 Fluid drainage and delivery device for wound treatment Pending 02-Jul-2021
EP-4251224-A1 Fluid drainage or delivery device for treatment site Pending 24-Nov-2020 A61M1/74
To view Aroa Biosurgery’s complete patent history, request access »

Aroa Biosurgery Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aroa Biosurgery Investments (1)

Aroa Biosurgery’s most recent deal was a Joint Venture with Appulse Medical. The deal was made on 01-Jun-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Appulse Medical 01-Jun-2018 Joint Venture Distributors (Healthcare)
To view Aroa Biosurgery’s complete investments history, request access »

Aroa Biosurgery Exits (1)

Aroa Biosurgery’s most recent exit was on 01-Jun-2018 from Appulse Medical. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Appulse Medical 01-Jun-2018 Completed
  • 2 buyers
To view Aroa Biosurgery’s complete exits history, request access »

Aroa Biosurgery FAQs

  • When was Aroa Biosurgery founded?

    Aroa Biosurgery was founded in 2008.

  • Where is Aroa Biosurgery headquartered?

    Aroa Biosurgery is headquartered in Auckland, New Zealand.

  • What is the size of Aroa Biosurgery?

    Aroa Biosurgery has 221 total employees.

  • What industry is Aroa Biosurgery in?

    Aroa Biosurgery’s primary industry is Medical Supplies.

  • Is Aroa Biosurgery a private or public company?

    Aroa Biosurgery is a Public company.

  • What is Aroa Biosurgery’s stock symbol?

    The ticker symbol for Aroa Biosurgery is ARX.

  • What is the current stock price of Aroa Biosurgery?

    As of 22-Apr-2025 the stock price of Aroa Biosurgery is $0.25.

  • What is the current market cap of Aroa Biosurgery?

    The current market capitalization of Aroa Biosurgery is $86.6M.

  • What is Aroa Biosurgery’s current revenue?

    The trailing twelve month revenue for Aroa Biosurgery is $46.8M.

  • What is Aroa Biosurgery’s annual earnings per share (EPS)?

    Aroa Biosurgery’s EPS for 12 months was -$0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »